Will vitamin E be the hope of patients with NASH and advanced fibrosis? - the reliability is worth discussing.
Sign Up to like & getrecommendations! Published in 2019 at "Hepatology"
DOI: 10.1002/hep.30603
Abstract: According to the article conducted by Eduardo et al.(1), the non-transplant survival rate of nonalcoholic steatohepatitis (NASH) patients with bridging necrosis and cirrhosis, which is a subtype of non-alcoholic fatty liver disease (NAFLD), was found to… read more here.
Keywords: patients nash; nash advanced; hope patients; vitamin hope ... See more keywords
Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2018.11.032
Abstract: BACKGROUND NGM282, an engineered analogue of the gut hormone FGF19, improves hepatic steatosis and fibrosis biomarkers in patients with non-alcoholic steatohepatitis (NASH). However, NGM282 increases serum cholesterol levels by inhibiting CYP7A1, which encodes the rate-limiting… read more here.
Keywords: patients nash; non alcoholic; rosuvastatin; cholesterol ... See more keywords
Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Gastroenterology"
DOI: 10.1097/mcg.0000000000001075
Abstract: Background: Nonalcoholic steatohepatitis (NASH) is a common cause of liver disease which can progress to cirrhosis and hepatocellular carcinoma (HCC). American Association for the Study of Liver Diseases (AASLD) guidelines recommend abdominal ultrasound, with or… read more here.
Keywords: nonalcoholic steatohepatitis; nash cirrhosis; surveillance; hcv cirrhosis ... See more keywords
Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of General Medicine"
DOI: 10.2147/ijgm.s339474
Abstract: Purpose Metabolic parameters are important for the development of portopulmonary hypertension (PoPH) during nonalcoholic steatohepatitis (NASH)-associated cirrhosis. This study evaluated patients with NASH-associated cirrhosis to determine metabolic risk factors for portopulmonary hypertension. Patients and Methods… read more here.
Keywords: portopulmonary hypertension; hypertension; patients nash; risk ... See more keywords